Website developed and funded by Kyowa Kirin Asia Pacific Pte. Ltd. © 2023 Kyowa Kirin Hong Kong Co., Limited HK-CRV-23-00021 NOV2023
Crysvita.Asia website is a branded website to deepen the understanding of healthcare professionals on the treatment and management of X-Linked Hypophosphatemia (XLH) and Crysvita® (Burosumab).
It showcases results from clinical trials and treatment management, as well as useful information, resources, links and contact information.
Login below or create an account to get all the latest updates on XLH and Crysvita (Burosumab) from this website: